Fine Organic Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 3:11 am

Competitors of Fine Organic Industries Ltd

All Competitor Stocks of Fine Organic Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:40 pm

Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 588.00 Cr.. The value appears to be declining and may need further review. It has decreased from 607.00 Cr. (Mar 2025) to 588.00 Cr., marking a decrease of 19.00 Cr..
• For Expenses, as of Jun 2025, the value is 466.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 487.00 Cr. (Mar 2025) to 466.00 Cr., marking a decrease of 21.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Mar 2025) to 21.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 21.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 27.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 97.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 20.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 38.19. The value appears strong and on an upward trend. It has increased from 31.68 (Mar 2025) to 38.19, marking an increase of 6.51.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 4:16 pm

Growth

Last Updated: September 4, 2025, 9:35 pm

Balance Sheet

Last Updated: August 11, 2025, 4:21 pm

Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,280.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,906.00 Cr. (Mar 2024) to 2,280.00 Cr., marking an increase of 374.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 31.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,108.00 Cr. (Mar 2024) to 2,511.00 Cr., marking an increase of 403.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 268.00 Cr. (Mar 2024) to 363.00 Cr., marking an increase of 95.00 Cr..
• For CWIP, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 35.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,774.00 Cr. (Mar 2024) to 2,085.00 Cr., marking an increase of 311.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,108.00 Cr. (Mar 2024) to 2,511.00 Cr., marking an increase of 403.00 Cr..

Notably, the Reserves (2,280.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
• For Diluted EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
• For Cash EPS (Rs.), as of Mar 25, the value is 151.21. This value is within the healthy range. It has decreased from 153.52 (Mar 24) to 151.21, marking a decrease of 2.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 740.10. It has increased from 692.42 (Mar 24) to 740.10, marking an increase of 47.68.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 199.11. This value is within the healthy range. It has increased from 197.62 (Mar 24) to 199.11, marking an increase of 1.49.
• For PBIT / Share (Rs.), as of Mar 25, the value is 182.06. This value is within the healthy range. It has increased from 179.31 (Mar 24) to 182.06, marking an increase of 2.75.
• For PBT / Share (Rs.), as of Mar 25, the value is 181.34. This value is within the healthy range. It has increased from 178.33 (Mar 24) to 181.34, marking an increase of 3.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 134.16. This value is within the healthy range. It has decreased from 135.20 (Mar 24) to 134.16, marking a decrease of 1.04.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
• For PBDIT Margin (%), as of Mar 25, the value is 26.90. This value is within the healthy range. It has decreased from 28.54 (Mar 24) to 26.90, marking a decrease of 1.64.
• For PBIT Margin (%), as of Mar 25, the value is 24.59. This value exceeds the healthy maximum of 20. It has decreased from 25.89 (Mar 24) to 24.59, marking a decrease of 1.30.
• For PBT Margin (%), as of Mar 25, the value is 24.50. This value is within the healthy range. It has decreased from 25.75 (Mar 24) to 24.50, marking a decrease of 1.25.
• For Net Profit Margin (%), as of Mar 25, the value is 18.12. This value exceeds the healthy maximum of 10. It has decreased from 19.52 (Mar 24) to 18.12, marking a decrease of 1.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has decreased from 19.40 (Mar 24) to 18.09, marking a decrease of 1.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 21.44 (Mar 24) to 17.88, marking a decrease of 3.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has decreased from 28.58 (Mar 24) to 24.30, marking a decrease of 4.28.
• For Return On Assets (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 16.35, marking a decrease of 3.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.08 (Mar 24) to 0.98, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 8.46. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 8.46, marking a decrease of 0.67.
• For Quick Ratio (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 2. It has decreased from 7.71 (Mar 24) to 6.76, marking a decrease of 0.95.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.28. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 7.28, marking an increase of 4.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.46. This value is below the healthy minimum of 20. It has increased from 6.69 (Mar 24) to 7.46, marking an increase of 0.77.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 20. It has increased from 5.89 (Mar 24) to 6.62, marking an increase of 0.73.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.54. This value exceeds the healthy maximum of 70. It has decreased from 93.31 (Mar 24) to 92.54, marking a decrease of 0.77.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.38. This value exceeds the healthy maximum of 70. It has decreased from 94.11 (Mar 24) to 93.38, marking a decrease of 0.73.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 278.05. This value is within the healthy range. It has increased from 249.04 (Mar 24) to 278.05, marking an increase of 29.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 188.34. This value is within the healthy range. It has increased from 171.61 (Mar 24) to 188.34, marking an increase of 16.73.
• For Enterprise Value (Cr.), as of Mar 25, the value is 11,296.88. It has decreased from 11,309.92 (Mar 24) to 11,296.88, marking a decrease of 13.04.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 4.98, marking a decrease of 0.35.
• For EV / EBITDA (X), as of Mar 25, the value is 18.50. This value exceeds the healthy maximum of 15. It has decreased from 18.67 (Mar 24) to 18.50, marking a decrease of 0.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
• For Retention Ratios (%), as of Mar 25, the value is 92.53. This value exceeds the healthy maximum of 70. It has decreased from 93.30 (Mar 24) to 92.53, marking a decrease of 0.77.
• For Price / BV (X), as of Mar 25, the value is 5.34. This value exceeds the healthy maximum of 3. It has decreased from 6.43 (Mar 24) to 5.34, marking a decrease of 1.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness